Fig. 4
From: NOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses

Expression and clinical staging analysis of NOX4. (A) T staging, (B) N staging, (C) Pathological stage.
From: NOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses
Expression and clinical staging analysis of NOX4. (A) T staging, (B) N staging, (C) Pathological stage.